Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

5 Stocks To Watch: AMSC, AXSM, CRON, DERM, VCYT

Published 03/26/2019, 01:14 AM
Updated 07/09/2023, 06:31 AM

The market had kind of a mixed session on Monday, down in the morning, up midday, back down, a rally to the end of the day, and a basing attempt after 5-waves down. We’ll see if that is meaningful or not. Many of the stocks we follow had a good day on Monday. Let’s take a look at some of them here.

American Superconductor Corporation (AMSC)

AMSC a former swing of ours from back in November, did very well. It went from 8 1/4 to all the way up to 17, more than double. It came down, tested the channel bottom, and then had a huge reversal on Monday, jumping 94 cents, or 7.74%, to 13.08, on big volume up from its usual 368,093 average. When you get that kind of engulfing reversal bar on big volume, it usually leads to more upside. Let’s watch the 13 3/4-14 zone, and if it gets through that, we should see 16, and maybe even 19. It could be interesting.

Axsome Therapeutics, Inc. (AXSM)

AXSM one of our swing trades, is doing great. Ever since it popped in January, it pulled back, we gave you a swing on it at 7-8, it more than doubled, and on Monday, it spiked up 3.34, or 26%, to 16.34, on 4.6 million shares. That’s the biggest volume since the breakout back in January. At this point, if we look at the long-term chart, you can see that there is a new, long-term high on this stock, and it might very well accelerate to 19-20 short-term.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Cronos Group Inc. (CRON)

CRON a marijuana stock, bounced off its 50-day and trendline on Monday, gaining 1.30, or 6.76%, to 20.53, on 16.2 million shares. That’s key area. It has to be stopped under 18.70, but if it gets above the 22 zone, it might run to the 25, even 30 zones going forward.

Dermira, Inc. (DERM)

DERM another swing trade of ours, popped a week ago and it’s been coiling ever since. On Monday, it popped out of the coil, bouncing 91 cents, or 7%, to 13.90, on 15 million shares. Let’s see if there’s a follow-through. It has to get through 14 3/4-15 1/4. The target, then, is near 17.

Veracyte, Inc. (VCYT)

VCYT was up 1.30, or 5.31%, to25.76, on 1 million shares. It broke through the top of the channel is a fifth-wave blow-off. The blow-off appears to be underway. It’s now been up for 11 out of 12 days and is looking like it doesn’t want to stop. What I would do is either sell some here or put a stop underneath the double bottom from Friday and Monday at the 23.85 range. If it runs, let it run. If it doesn’t run and rolls over, you’re out.

Stocks on the long side

American Superconductor Corporation (AMSC), Anavex Life Sciences Corp. (AVXL), Axsome Therapeutics, Inc. (AXSM), Catalyst Pharmaceuticals, Inc. (CPRX), Cronos Group Inc. (CRON), CV Sciences, Inc. (CVSI), Dermira, Inc. (DERM), Eldorado Gold Corporation (EGO), Intelligent Systems Corporation (INS), Direxion Daily Jr Gold Miners Bull 3X ETF (JNUG), Direxion Daily Gold Miners Bull 3X ETF (NUGT), Luna Innovations Incorporated (LUNA), 3Pea International, Inc. (TPNL), Veracyte, Inc. (VCYT), and Voyager Therapeutics, Inc. (VYGR).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Watch video here.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.